Tag: type

New way to prevent heart disease in type 1 diabetes

Scientists reveal the mechanism which allows a commonly prescribed drug for type 2 diabetes to prevent heart disease in patients with type 1 diabetes–and could lead to new treatments. Metformin is an inexpensive treatment that is often used for type 2 diabetes to lower blood sugar levels by reducing glucose production in the liver. The

Pfizer Recalls a Type of Children’s Liquid Advil

WEDNESDAY, Aug. 29, 2018 — One lot of 4-ounce bottles of Children’s Advil Suspension Bubble Gum Flavored is being recalled because a packaging problem could lead to an overdose, Pfizer Consumer Healthcare says. The dosage cup is marked in teaspoons while the dosage instructions on the label use milliliters, the company explained. Common symptoms associated

Joslin researchers report excessive fetal growth despite well-controlled type 1 diabetes

A new study has shown that despite excellent glycemic control and low glycemic variability throughout their pregnancies, women with type 1 diabetes tended to give birth to infants who were large for gestational age. Researchers documented elevated fetal weight and abdominal circumference percentages throughout the pregnancies that were consistent with accelerated prenatal growth, as documented

Stigma adds to burden of type 1 diabetes

(HealthDay)—Michael Wright was just 16 when he was diagnosed with type 1 diabetes, and although his friends supported him, he always felt different. “I would do my injections and testing in private [in another room or even the bathroom] to avoid having conversations about diabetes with people,” he said. It was also to avoid stares

Towards personalised medicine: One type of data is not enough

EMBL researchers have designed a computational method to jointly analyse multiple types of molecular data from patients in order to identify molecular signatures that distinguish individuals. The method is called Multi-Omics Factor Analysis (MOFA), and was published in Molecular Systems Biology today. MOFA could be particularly useful for understanding cancer development, improving diagnosis and suggesting

Drug combination slows growth of most common type of advanced breast cancer

The combination of taselisib and fulvestrant has shown to slow the growth of cancer in post-menopausal women with estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER2) negative, PIK3CA-mutant, inoperable, locally advanced or metastatic breast cancer. Researchers from Memorial Sloan Kettering Cancer Center (MSK) presented this data, from the SANDPIPER trial, in a press conference

Type 2 diabetes: Sexual orientation may influence risk

The National Institutes of Health (NIH) estimate that more than 30 million people in the United States live with type 2 diabetes. Many of the risk factors for diabetes are lifestyle habits that can be changed. Being physically active, eating right, and trying to maintain a healthy weight can all lower the risk. Some other

This Type of Exercise May Help Relieve Depression

Strength training is good for your body and your mind, according to a new review of more than 30 previously published studies. The paper, published in the journal JAMA Psychiatry, found that resistance exercise training (RET), such as weightlifting and strength training, is associated with a significant reduction in depressive symptoms. It also, of course,

Evening preference linked to higher BMI in type 2 diabetes

(HealthDay)—Evening preference and a later breakfast are associated with elevated body mass index (BMI) in adults with type 2 diabetes, according to a study published online April 13 in Diabetic Medicine. Hataikarn Nimitphong, M.D., from Mahidol University in Bangkok, and colleagues examined the correlations among meal timing, morning-evening preference, and BMI in 210 non-shift workers

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings. The research, led by scientists from Imperial College London and published in the Journal of the American Medical Association, studied three types of diabetes treatment: sodium-glucose cotransporter 2 (SGLT-2) inhibitors, glucagon-like